1. Cougard, P., Calender, A., Prove, C., Goudet, P., Carnaille, B., Sarfati, E., Denizot, A., Kraimps. J.L., Chabrier, G., Murat, A., Peix, J.L., GENEM 1: L’hyperparathyroïdie, signal privilégié du dépistage des néoplasies endocriniennes multiples de type 1 (NEM1). Rev. Fr. Endocrinol. Clin. 36:360, 1995
2. Benson, L., Ljunghall, S., Akerström, G., Oberg, K.: Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1: a new at physiopathology. Ann. J. Med. 82:731, 1987
3. Larsson, C., Friedman, E.: Localization and identification of the multiple endocrine neoplasia type 1 disease gene. Endocrinol. Metab. Clin. North Am. 23:67, 1994
4. Giraud, S., Zhang, C.X., Serova-Sinilnikova, O., Wautot, V., Salandre, J., Buisson, N., Waterlot, C., Bauters, C., Porchet, N., Aubert, J.P., Emy, P., Cadiot, G., Delemer, B., Chabre, O., Niccoli, P., Leprat, F., Duron, F., Emperauger, B., Cougard, P., Goudet, P., Sarfati, E., Riou, J.P., Guichard, S., Rodier, M., Calender, A.: Germline mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 63:455, 1998
5. Breslow, N.E., Day, N.E.: The Analysis of Case-control Studies. Statistical Methods in Cancer Research, vol. 1, no. 32, Lyon, International Agency for Research on Cancer Scientific Publications, 1980